A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Perianal Crohn's Disease
Interventions
DRUG

BLI-1300 low dose

topical ointment

DRUG

BLI-1300 high dose

topical ointment

DRUG

placebo

topical ointment

Trial Locations (17)

10029

Mount Sinai Medical Center, New York

11021

Long Island Clinical Research Associates, Great Neck

11042

New York Center for Clinical Research, Lake Success

17033

Penn State Hershey Medical Center, Hershey

20815

Chevy Chase Clinical Research, Chevy Chase

21201

University of Maryland, Baltimore

27599

UNC School of Medical, Chapel Hill

28801

Asheville Gastroenterology, Asheville

29425

Medical University of South Carolina, Charleston

32256

Borland Groover Clinic, Jacksonville

37212

Vanderbilt University Medical Center, Nashville

44106

University Hospitals Case Medical Center, Cleveland

45219

Consultants for Clinical Research, Cincinnati

55905

Mayo Clinic, Rochester

92801

ACRI - Phase I, Anaheim

94115

University of California - San Francisco, San Francisco

08053

South Jersey Gastroenterology, Marlton

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY